KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Other financing activities (2020 - 2025)

Historic Other financing activities for Colgate Palmolive (CL) over the last 6 years, with Q3 2025 value amounting to $9.0 million.

  • Colgate Palmolive's Other financing activities fell 7954.55% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.0 million, marking a year-over-year increase of 816.33%. This contributed to the annual value of -$91.0 million for FY2024, which is 60555.56% down from last year.
  • Colgate Palmolive's Other financing activities amounted to $9.0 million in Q3 2025, which was down 7954.55% from $104.0 million recorded in Q2 2025.
  • In the past 5 years, Colgate Palmolive's Other financing activities ranged from a high of $104.0 million in Q2 2025 and a low of -$92.0 million during Q4 2024
  • Its 5-year average for Other financing activities is $1.7 million, with a median of -$5.5 million in 2021.
  • Its Other financing activities has fluctuated over the past 5 years, first crashed by 140000.0% in 2021, then soared by 62000.0% in 2025.
  • Over the past 5 years, Colgate Palmolive's Other financing activities (Quarter) stood at -$15.0 million in 2021, then surged by 233.33% to $20.0 million in 2022, then soared by 140.0% to $48.0 million in 2023, then tumbled by 291.67% to -$92.0 million in 2024, then skyrocketed by 109.78% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $104.0 million for Q2 2025, and $32.0 million during Q1 2025.